Schaeffer C, De Fusco M, Pasqualetto E, Scolari C, Izzi C, Scolari F
Dis Model Mech. 2023; 16(6).
PMID: 37283036
PMC: 10259838.
DOI: 10.1242/dmm.049963.
Lang S, Nguyen D, Bhadra P, Jung M, Helms V, Zimmermann R
Front Physiol. 2022; 13:833540.
PMID: 35899032
PMC: 9309488.
DOI: 10.3389/fphys.2022.833540.
Teja Dondapati D, Cingaram P, Ayaydin F, Nyeste A, Kanyo A, Welker E
Membranes (Basel). 2021; 11(12).
PMID: 34940479
PMC: 8704586.
DOI: 10.3390/membranes11120978.
Zimmermann R, Lang S, Lerner M, Forster F, Nguyen D, Helms V
Int J Mol Sci. 2021; 22(23).
PMID: 34884833
PMC: 8658024.
DOI: 10.3390/ijms222313028.
Bhadra P, Schorr S, Lerner M, Nguyen D, Dudek J, Forster F
Molecules. 2021; 26(12).
PMID: 34208277
PMC: 8230838.
DOI: 10.3390/molecules26123591.
Recent Advances in Chemical Biology of Mitochondria Targeting.
Wang H, Fang B, Peng B, Wang L, Xue Y, Bai H
Front Chem. 2021; 9:683220.
PMID: 34012953
PMC: 8126688.
DOI: 10.3389/fchem.2021.683220.
SecY-mediated quality control prevents the translocation of non-gated porins.
Jung S, Bader V, Natriashvili A, Koch H, Winklhofer K, Tatzelt J
Sci Rep. 2020; 10(1):16347.
PMID: 33004891
PMC: 7530735.
DOI: 10.1038/s41598-020-73185-y.
Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia.
Van Nieuwenhove E, Barber J, Neumann J, Smeets E, Willemsen M, Pasciuto E
J Allergy Clin Immunol. 2020; 146(5):1180-1193.
PMID: 32325141
PMC: 7649975.
DOI: 10.1016/j.jaci.2020.03.034.
Proteasomal Inhibition Redirects the PrP-Like Shadoo Protein to the Nucleus.
Kang S, Mays C, Daude N, Yang J, Kar S, Westaway D
Mol Neurobiol. 2019; 56(11):7888-7904.
PMID: 31129810
PMC: 6815274.
DOI: 10.1007/s12035-019-1623-1.
The signal peptide plus a cluster of positive charges in prion protein dictate chaperone-mediated Sec61 channel gating.
Ziska A, Tatzelt J, Dudek J, Paton A, Paton J, Zimmermann R
Biol Open. 2019; 8(3).
PMID: 30745438
PMC: 6451349.
DOI: 10.1242/bio.040691.
Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases.
Sarnataro D
Int J Mol Sci. 2018; 19(10).
PMID: 30304819
PMC: 6213118.
DOI: 10.3390/ijms19103081.
Proteomics reveals signal peptide features determining the client specificity in human TRAP-dependent ER protein import.
Nguyen D, Stutz R, Schorr S, Lang S, Pfeffer S, Freeze H
Nat Commun. 2018; 9(1):3765.
PMID: 30217974
PMC: 6138672.
DOI: 10.1038/s41467-018-06188-z.
Maternal imprinting on cognition markers of wild type and transgenic Alzheimer's disease model mice.
Zamarbide M, Gil-Bea F, Bannenberg P, Martinez-Pinilla E, Sandoval J, Franco R
Sci Rep. 2018; 8(1):6434.
PMID: 29691440
PMC: 5915602.
DOI: 10.1038/s41598-018-24710-7.
Impaired transport of intrinsically disordered proteins through the Sec61 and SecY translocon; implications for prion diseases.
Jung S, Tatzelt J
Prion. 2018; 12(2):88-92.
PMID: 29388511
PMC: 6016518.
DOI: 10.1080/19336896.2018.1435936.
The Sec61/SecY complex is inherently deficient in translocating intrinsically disordered proteins.
Gonsberg A, Jung S, Ulbrich S, Origi A, Ziska A, Baier M
J Biol Chem. 2017; 292(52):21383-21396.
PMID: 29084847
PMC: 5766967.
DOI: 10.1074/jbc.M117.788067.
Regulation of sub-compartmental targeting and folding properties of the Prion-like protein Shadoo.
Pepe A, Avolio R, Matassa D, Esposito F, Nitsch L, Zurzolo C
Sci Rep. 2017; 7(1):3731.
PMID: 28623368
PMC: 5473912.
DOI: 10.1038/s41598-017-03969-2.
Cellular prion protein is present in mitochondria of healthy mice.
Faris R, Moore R, Ward A, Race B, Dorward D, Hollister J
Sci Rep. 2017; 7:41556.
PMID: 28148964
PMC: 5288712.
DOI: 10.1038/srep41556.
Protein folding as a driving force for dual protein targeting in eukaryotes.
Kalderon B, Pines O
Front Mol Biosci. 2015; 1:23.
PMID: 25988164
PMC: 4428415.
DOI: 10.3389/fmolb.2014.00023.
Cotranslational stabilization of Sec62/63 within the ER Sec61 translocon is controlled by distinct substrate-driven translocation events.
Conti B, Devaraneni P, Yang Z, David L, Skach W
Mol Cell. 2015; 58(2):269-83.
PMID: 25801167
PMC: 4402133.
DOI: 10.1016/j.molcel.2015.02.018.
Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
Beland M, Roucou X
Prion. 2013; 8(1):106-10.
PMID: 24335160
PMC: 7030915.
DOI: 10.4161/pri.27438.